Introduction
Epigenetics has historically referred to heritable modifications resulting in phenotypes that are not directly dependent on the DNA sequence inherited. However, in recent years the rapid expansion of epigenetic research into DNA methylation, histone modifications, and chromatin structure has broadened the definition of epigenetic heritability to include long-lived but reversible modifications to nucleotides and chromosomes. With this larger umbrella of epigenetic mechanisms has come greater complexity in defining the set of underlying epigenetic rules. Box 1 provides a current definition of epigenetics, lists the major categories of epigenetic layers and players, gives examples of what is and is not epigenetics, and dispels some epigenetic urban myths.
Neuroscientists have understandably been drawn to the field of epigenetics because it can help explain complex transcriptional regulation that is not fully explained by inducible and tissue-specific transcription factors alone. Epigenetics is also appealing because it offers a potential explanation for variable phenotypic outcomes from similar genetic backgrounds. Specifically, how do early life experiences during critical periods for learning and memory or establishment of the hypothalamic-pituitary-adrenal (HPA) axis have long-lived effects on transcription lasting into adulthood? How are transcriptional patterns that define neuronal networks maintained and further refined with activity? How does drug abuse in adolescence set up a behavioral pattern of addiction? Epigenetic modifications appear to be especially important for genes encoding proteins acting at the synapse [1-3], so epigenomic investigations may point to potential druggable protein targets using existing medications in the treatment of neurodevelopmental and psychiatric disorders. In addition, epigenetic mechanisms exist in a metastable state, so an attractive possibility is the design of therapies to reverse epigenetic states in the brain without disrupting the underlying genetic state.
However, caution should be exerted in not putting the cart before the horse in this line of research. Epigenetics is still a young field and the rules of how epigenetic modifications affect gene expression and may be involved in specific disease states have yet to be fully understood. With the advent of genome-wide technologies, the view of the epigenome has broadened considerably, but this new information has often challenged many of the past assumptions about epigenetic control of gene expression [4] . Here, we review our current understanding of the individual layers of epigenetic information and how they are important to neurons, primarily during early life. We define layers as structural components of DNA and chromatin, in contrast to players, which are active complexes and enzymes required for epigenetic layers.
The neuronal methylome
The addition of a methyl group to the fifth carbon of cytosine (5meC) is primarily observed at CpG sites in the mammalian genome, although non-CpG methylation is also observed in plants and in embryonic stem (ES) cells and neurons in mammals [5] . Brain DNA has one of the highest levels of 5meC in the human body. 5meC can also be converted to 5-hydroxymethylcytosine (5hmC) in the presence of TET1 [6, 7] , and 5hmC is implicated in demethylation of the paternal genome in early mouse (Mus musculus) embryos and the self-renewal capacity of mouse ES cells, perhaps through demethylation of the Nanog promoter [8] . 5hmC levels are particularly high in brain compared to other tissues and Purkinje neurons compared to granular neurons of the cerebellum [6] . Although 5hmC appears to be an important transition state in the dynamic methylation patterns of neurons, it is far less abundant than 5meC, even in Purkinje neurons. Furthermore, most methods used to investigate DNA methylation that involve either bisulfite conversion or methyl-sensitive restriction enzymes cannot distinguish between 5meC and 5hmC.
